OBJECTIVE-Hyperglycemia is a risk factor for microvascular complications and may increase the risk of cardiovascular disease in patients with type 2 diabetes. The primary efficacy measurement was mean placebo-corrected change in A1C from baseline to week 26 in the intent-to-treat population (last observation carried forward). RESULTS-The least squares (LS) mean change in A1C from baseline… Continue reading OBJECTIVE-Hyperglycemia is a risk factor for microvascular complications and may increase